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Asp6 peptide bond upon TCR binding of the pMHC complex. Molecular dynamics simulations of
pMHC/TCR structures, with the EENLLDFVRF peptide in cis and trans conformations have been
employed in order to examine the structure and dynamics of the pMHC complex with such an unu-
sual conformation. The results, based on MM-PBSA free energy computations as well as buried sur-
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the pMHC complex with the Leu5-Asp6 peptide bond in cis conformation. It is the ﬁrst time that this
notable conformational feature of T-cell epitope is investigated.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Flexibility in peptide binding by protein receptors is a well
known issue [1]. Targeting this feature of peptides conformation
in immunological complexes can have signiﬁcant impact in design-
ing successful vaccines [2]. Cis–trans isomerization has been
observed mainly in proline residues in proteins [3,4], although it
can be found in other residues as well [5]. The pore functionality
of a neurotransmitter-gated ion channel at Cys-loop receptor
super-family is a classical paradigm of how cis–trans isomerization
can affect biological binding and activity [6]. In small peptides,
cis–trans isomerization can be inﬂuenced by speciﬁc side chain
interactions [7], while in proteins it can be modulated by enzy-
matic action [8]. Cis–trans isomerization has been observed in both
B-cell epitopes [9,10] and T-cell epitopes in peptide/MHC com-
plexes [11]. It has been noted that cis–trans isomerization must
be carefully taken into account in predicting peptide conforma-
tions bound to the major histo-compatibility complex (MHC)
molecules [12].
Recently, the X-ray structure of the Epstein–Barr virus
determinant peptide, with sequence E1ENLLDFVRF10, bound to
HLA-B*4405 molecule (pMHC complex) has been determined
[13], along with the X-ray structure of the pMHC complexed withchemical Societies. Published by EDM1 T-cell receptor (TCR). The authors compared the X-ray
structure of HLA-B*4405EENLLDFVRF with HLA-B*4402EENLLDFVRF and
HLA-B*4403EENLLDFVRF X-ray structures and concluded that peptide
ﬂexibility was critical in preferential engagement with HLA-
B*4405 in comparison to HLA-B*4402/03, resulting in ﬁnetuning
of T cell responses between closely related allotypes. One striking
feature of the peptide’s conformation in pMHC/TCR complex was
the adoption of cis isomerization state in Leu5-Asp6 peptide bond,
while the same bond was found in trans isomerization state in the
pMHC complex.
The rules by which the TCRs interact with pMHC complexes are
not yet clearly understood [14,15], but there is a continuous
increase in our knowledge as more pMHC/TCR complexes appear
in the Protein Data Bank. Currently, there is no other example
described in the literature with peptide in pMHC/TCR complex
possessing a cis peptide bond, after the formation of pMHC/TCR
complex. Of course, cis–trans isomerization might not be consid-
ered a global feature of peptide structure in pMHC/TCR complexes,
and this observation cannot be generalized in all pMHC/TCR
complexes. However, the case described here is notable, as it is
seen in biological afﬁnity experiments [13].
Molecular dynamics simulations have been extensively used in
immunological and pharmaceutical research during past years
[16,17]. It has been argued that this approach can augment our
knowledge gained from experimental research [18,19]. Thus,
extensive molecular dynamics studies of pMHC/TCR complexes
are presented here, with the aim to explore the dynamic propertieslsevier B.V. All rights reserved.
486 A. Stavrakoudis / FEBS Letters 585 (2011) 485–491of the peptide’s conformations in the two complexes and to explain
why the TCR prefers to bind a pMHC complex with a peptide in cis
conformation.
2. Methods
2.1. System setup and simulation
Initial coordinates the TCR–HLA-B*4405EENLLDFVRF complex were
downloaded from Protein Data Bank [20], access code 3dxa [13]. InFig. 1. Root mean square ﬂuctuation (RMSF) of Ca atoms and root mean square deviation
positions from MD trajectories to the initial coordinates. Results from different trajectorie
(A) RMSF of Ca atoms of MHC chain a, (B) RMSF of Ca atoms of MHC chain b, (C) RMSF o
RMSD of backbone atoms of MHC chain a, (F) RMSD of backbone atoms of MHC chain b, (G
chains a and b, respectively (D,E).this structure, the x dihedral angle between Leu5 and Asp6
residues is found 16.6, thus in cis conformation. This complex will
be referred as TCR–HLAcpep hereafter. Another complex, with the
peptide in trans conformation was also modeled in this study.
The peptide structure from the HLA-B*4405–peptide complex
(TCR free complex) was extracted and its coordinates were super-
imposed onto the coordinates of the peptide in the TCR–HLAcpep
complex. These coordinates were taken from the PDB structure
3dx8 [13], where the peptide lies in the trans conformation. The
rest of the molecular complex (MHC + TCR) was left untouched.(RMSD) time series of backbone atoms (N, Ca, C) after ﬁtting the corresponding atom
s (TCR–HLAcpep and TCR–HLAcpep) are indicated with different line colors and styles.
f Ca atoms of the peptide, (D) RMSF of Ca atoms of chains a, b (D,E) of DM1 TCR, (E)
) RMSD of backbone atoms of the peptide, (H) RMSD of backbone atoms of the TCR’s
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plexes were treated under exactly the same simulation protocol.
Topology and force ﬁeld parameters for all atoms were assigned
from the CHARMM27 parameter set [21]. Hydrogen atoms were
added with the VMD program [22] and its autopsf utility. Proton-
ation status of Histidine side chains was determined with the RE-
DUCE program [23]. The protein complexes was centered in a
rectangular box with dimensions 87.9  92.4  175.6 Å3. The box
was ﬁlled with TIP3P water molecules and neutralized with the
addition of 27 Na+ and 15 Cl ions respectively, to approximate a
0.1 mM ion concentration. The minimum distance of any protein
atom to the edges of the simulation box was 17 Å in order to avoid
simulation artifacts [24]. Total number of atoms of the whole sys-
tem was 131408.
Non-bonded van der Waals interactions were gradually turned
off at a distance between 10 and 12 Å [25]. Long range electrostat-Table 1
Backbone dihedral angles of the peptide in tpep and cpep trajectories. The values
observed in X-ray structures (PDB codes 3dxa and 3dx8, respectively) are also listed
as a reference. Parentheses indicate the estimated standard deviations with the
Yamartino method (see Section 2 for details).
Dihedral PDB MD
tpep cpep tpep cpep
Glu2 / 79.9 90.9 93.8 (14.9) 101.7 (13.6)
Glu2 w 164.6 169.7 176.4 (8.3) 168.9 (10.9)
Asn3 / 90.6 126.5 83.6 (11.3) 90.2 (16.0)
Asn3 w 126.6 117.6 149.6 (11.6) 96.4 (20.9)
Leu4 / 95.6 109.9 97.4 (12.5) 124.3 (16.5)
Leu4 w 86.9 136.7 107.1 (26.4) 121.2 (13.7)
Leu5 / 84.1 70.9 100.0 (15.3) 75.3 (12.1)
Leu5 w 125.1 70.6 88.6 (20.2) 55.3 (8.3)
Asp6 / 84.9 105.6 83.8 (15.6) 88.7 (9.7)
Asp6 w 125.9 35.3 77.7 (15.6) 21.8 (11.3)
Phe7 / 57.2 53.5 107.3 (17.3) 69.8 (10.3)
Phe7 w 26.8 4.7 40.6 (26.0) 52.3 (12.8)
Val8 / 85.7 67.6 92.6 (16.6) 97.4 (13.4)
Val8 w 118.1 113.7 86.4 (15.3) 83.9 (15.3)
Arg9 / 148.0 143.3 117.5 (15.0) 106.7 (14.0)
Arg9 w 156.6 153.1 155.9 (14.1) 122.5 (15.2)
Fig. 2. Ramachandran maps of the backbone dihedral angles (/, w) of the Leu5-Asp6 reg
the right column, while the maps obtained from the left column are plotted in the left co
and they have been binned every 10. Backbone dihedral angle w is plotted horizontally w
of frames in each bin.ics were calculated with the PME method [26]. Non-bonded forces
and PME electrostatics were computed every second step. Pair list
was updated every 10 steps. Bonds to hydrogen atoms were con-
strained with the SHAKE method [27] allowing a 2 fs time step
for integration. Each system was initially subjected to energy min-
imization with 5000 steps. The temperature of the system was
then gradually increased to 310 K, with Langevin dynamics using
the NVT ensemble, during a period of 3000 steps, by stepwise reas-
signment of velocities every 500 steps. The simulation was contin-
ued at 310 K for 200000 steps (400 ps). During minimization and
equilibration phases, protein backbone atoms (N, Ca, C0, O) were re-
strained to their initial positions with a force constant of
50 kcal mol1 Å2. The system was equilibrated for another
400 ps with the force constant reduced to 5 kcal mol1 Å2. Finally,
400 ps of NVT simulation at 310 K was performed with total elim-
ination of the positional restraints. The simulations were passed to
the productive phase, by applying constant pressure with the
Langevin piston method [28]. Pressure was maintained at 1 atm
and temperature at 310 K. Results are based to a period of 20 ns
of these isothermal-isobaric (NPT) runs. Snapshots were saved to
disk at 1 ps interval for further structural analysis.
2.2. Trajectory analysis
Trajectory analysis of backbone dihedral angles, non-bonded
interactions, etc., was performed with the Eucb [29,30] software
package. b-Turn classiﬁcations were based on geometrical charac-
teristics of the backbone conformation [31]. Initially, a b-turn was
accepted if dðCai  Caiþ3Þ 6 7 Å and j aðCai  Caiþ1  Caiþ2  Caiþ3Þ j<
90, where d is the distance and a is the dihedral angle between
the corresponding atoms. Further classiﬁcation of the b-turn was
based on hydrogen bond patterns and backbone dihedral values
of the i + 1 and i + 2 residues. Appropriate corrections have been ta-
ken into consideration for the calculation of angular/circular statis-
tics [32,33]. Secondary structure analysis was performed with
STRIDE [34]. Structural ﬁgures were prepared with PyMOL
(http://www.pymol.org).ion of the peptide. The maps obtained from the pMHC/TCR trajectory are plotted in
lumn. Dihedral data values have been extracted for 20000 frames of the trajectories
hile dihedral angle w is plotted vertically. The color sidebar indicates the percentage
Fig. 3. Probability density plot of the Leu5 x angle of the peptide in cpep and tpep
trajectories.
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Dihedral principal components analysis [35,36] of the peptide
was performed with the Carma [37] software package.
2.4. MM-PBSA calculation of DGbinding
The binding free energy of the association of two molecules
(A + B? AB) can be estimated, according to the MM-PBSA ap-
proach [38,39]. In the current study, the last 10 ns were used for
obtaining trajectory averages, assuming that equilibrium was
reached after the ﬁrst 10 ns of the simulation. 10000 structures
were utilized for the calculation of SASA and molecular mechanics
calculations, while 50 structures (one every 200 frames) were used
for the calculation of the Gelecsolv with the APBS [40,41] software. En-
tropy terms were not included in the current calculations.3. Results
3.1. Backbone dynamics of the peptide
Root mean square ﬂuctuation (RMSF) of Ca atoms during MD
trajectories and time evolution of root mean square deviation
(RMSD) of backbone atoms (N, Ca, C0) are presented in Fig. 1. In
general, it can be seen that both trajectories were quite stable dur-
ing the 20 ns of molecular dynamics simulations.
All protein chains in the TCR–HLAcpep complex showed lower
RMSD values than the TCR–HLAtpep complex. The difference, as it
is revealed form the time evolution plots was approximately 1 Å.
The value itself is not that big. However, the fact that the peptide,
the MHC molecule and TCR, all showed as increased ﬂexibility in
the TCR–HLAtpep is notable. Since the difference between the two
simulated complexes was only a cis/trans peptide bond at the
Leu5-Asp6 region then the observed increased ﬂexibility in the
TCR–HLAtpep can be ascribed to this conformational transition.
Table 1 lists the values of backbone dihedral angles of residues
2–9 of the peptide, observed in the X-ray structures, as well as the
corresponding average values from the TCR–HLAcpep and TCR–
HLAcpep trajectories. A notable difference in peptide’s backbone
dihedral angles is the opposite sign of the w dihedral angle of res-
idue Leu5. The corresponding value averaged at 88.6 and 55.3
during the TCR–HLAcpep and TCR–HLAtpep. Thus, differences of
approximately 145 have been recorded, indicating a major confor-
mational difference in this region of the peptide. The correspond-
ing difference in the X-ray structure is 175. The difference in
backbone dihedral angles around the Leu5-Asp6 region is high-
lighted in Fig. 2.
The most striking feature of the backbone’s conformational
transition after the TCR binding of the pMHC binding was the cis
peptide bond observed in pMHC/TCR structure, at position Leu5-
Asp6 (PDB code 3dxa). The same peptide bond was found in trans
isomerization state in pMHC complex (PDB code 3dx8). This is the
ﬁrst observation of such an isomerization in peptide’s structure
after TCR binding of a pMHC complex, and its occurrence must
be noted. However, this can not be generalized as a global property
of the DM1 T-cell receptor. Most likely, this is an allele dependent
feature [14]. Fig. 3 show the probability density of the Leu5x angle
with values obtained from the pMHC and pMHC/TCR trajectories.
As it can be expected, the x angle did not show any transition.
Non-proline cis peptide bonds are relatively rare in proteins and
peptides [5]. Moreover cis peptide bonds in Leu-Asp fragments
are particularly rare [3]. From this point of view, the cis–trans
isomerization of the Leu5-Asp6 peptide bond is rather unexpected,
particularly due to the restrained position of the peptide into the
MHC’s binding groove, which leaves pretty much less space formovement than the free state of the peptide in a solution. Taken
into consideration that this region of the peptide lies in the heart
of pMHC/TCR interaction [13], the proposition that the TCR is
responsible for this isomerization comes out as logical conse-
quence of this interaction. Thus, the T-cell receptor can only be
adapted on the pMHC interface, but it can trigger major conforma-
tional transitions at the binding interface.
Analysis of the secondary structure of the peptide’s structure
with the STRIDE program [34] revealed that the peptide remained
in b-turn conformational state in the Leu5-Val8 region. Although
this b-turn was not accompanied by a stabilizing hydrogen bond
(type IV turn), it is proposed that the term ‘‘turn’’ to be used in-
stead of the ‘‘bulged’’ conformation, as this secondary structure
plays important role in peptide’s recognition in immunological
complexes [42,43]. The b-turn remained in presence for approxi-
mately 95% of the trajectory frames in both pMHC/TCR complexes.
3.2. Dihedral angle principal component analysis
Dihedral angle principal component analysis has been applied
in order to explore the energy landscape of the peptide in TCR–
HLAcpep TCR–HLAtpep complexes. Fig. 4 shows the projection of
the backbone dihedral angles of the peptide on the planes of the
ﬁrst three principal components. The main difference between
the two complexes is that in the TCR–HLAcpep case a dominant con-
formation can be observed, which is not the case in the TCR–HLAt-
pep trajectory. A sufﬁcient sampled single-stated structure should
lead (in such projections) in a two dimensional Gaussian-type
graph, centered at the origin. This is pretty much what one can
observe in the TCR–HLAcpep case. However, the TCR–HLAtpep trajec-
tory (bottom row) deviates signiﬁcantly from this representation.
It is clearly stated that the peptide sampled two to three distinct
conformational states that differed form those of the TCR–HLAcpep
trajectory. These projections corroborate the previously analyzed
Ramachandran maps and backbone dihedral angle analysis of
the peptide in the TCR–HLAcpep and TCR–HLAtpep complexes
respectively.
3.3. Interactions at the pMHC/TCR interface
Fig. 5 show the time evolution between the number of hydro-
gen bonds between various parts of the molecular complexes. As
it can be seen from this ﬁgure the interactions between MHC
chain a and TCR chains a, b (parts (A) and (B), respectively) are
approximately the same. Interestingly, during the second part of
the trajectory, the number of hydrogen bonds in TCR–HLAtpep
complex exceeded slightly the corresponding number of the
TCR–HLAcpep complex. What really different between the two com-
plexes was the number of hydrogen bond interactions between the
Fig. 4. Dihedral principal component analysis of the peptide. All diagrams shown in this ﬁgure are pseudo-color representations of density functions corresponding to the
projections of the ﬂuctuations of the peptides backbone dihedral angles (/, w) on the planes of the top three eigenvectors. The density function shown is DG = kBTln(p/pmax)
where kB is the Boltzmann constant, T is the temperature in Kelvin, and p and pmax are probabilities obtained from the distribution of the principal components for each
structure (frame) from the corresponding trajectory. The DG values obtained from this procedure are on an arbitrary scale in the sense that they depend on the binning
procedure used for calculating the p and pmax values. For all diagrams of this ﬁgure, the raw data were binned on a square matrix of size N/2, where N is the number of frames
of the corresponding trajectory.
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Fig. 5, respectively.) Thus, while the TCR–HLAcpep complex showed
remarkably constant hydrogen bond interactions, the TCR–HLAtpep
complex exhibited a gradual loss of hydrogen bond interactions
between the peptide and the TCR. This fact was observed for both
chains of TCR. Approximately 3–4 hydrogen bonds were lost from
peptide/TCRa and peptide/TCRb interfaces. Although the time scale
of this simulation work might not be long enough to address the
full dynamics of such a big protein complex, the trend in destruc-
tion of the hydrogen bond network is clearly and undoubtedly
observed.
Taking all of these interactions additively, one can lead to part
(E) of Fig. 5, where the total number of hydrogen bond interactions
are plotted against simulation time. The difference in this number
between the TCR–HLAcpep and TCR–HLAtpep complexes is also high-
lighted (green dashed line).
Another indication of the instability of the pMHC/TCR interac-
tion in the TCR–HLAtpep complex comes from the hydration of
the peptide. Although, the resolution (3.5 Å) of the original
complex did not allow the identiﬁcation of water molecules in
the X-ray structure, the evidence provided here corroborates the
hypothesis that the TCR–HLAtpep is relatively unstable in compari-
son with the TCR–HLAcpep complex. Part (F) of the Fig. 5 displays
the time evolution of the hydrogen bonds between peptide resi-
dues in the region Glu2-Arg9. N- and C-terminus residues were
excluded from the current analysis due to their proximity with
the bulk solvent. The time series of this quantity was found pretty
stable in the TCR–HLAcpep complex, but it showed a constant slight
increase over simulation time. The increased hydration of the pep-
tide, which lies in the heart of pMHC/TCR interaction interface, is
strongly indicative of the destruction of this interface. The peptideprefers the solvent interaction, which leads to a loss of the binding
interface. This observation is in line with the results discussed in
the previously, where the decrease in pMHC/TCR interactions were
shown.
3.4. Buried surface area analysis
The loss in hydrogen bond interaction contacts can be pretty
well summarized by plotting the buried surface are between
the pMHC and TCR parts of the TCR–HLAcpep and TCR–HLAtpep
complexes, as it is shown in the Fig. 6. Both complexes, exhibited
approximately the same BSA value during the ﬁrst part of the
simulation. However, the BSA time series signiﬁcantly diverged
in the TCR–HLAcpep and TCR–HLAtpep cases during the second part.
The loss of the BSA, which is directly connected to the binding
strength, in remarkable agreement with the loss of the hydrogen
bond interactions and the hydration of the peptide in the TCR–
HLAtpep case. Thus, accumulated evidence is provided that the
TCR–HLAtpep complex is relatively unstable and that DM1 TCR pre-
fers to bind the HLA-B44–peptide complex with the Leu5-Asp6
peptide bond in the cis conformation.
3.5. Energetic analysis of pMHC/TCR interactions
The structural observations of the instability of the TCR–HLAtpep
are very well reﬂected in the energetic analysis of the complexes.
Computation of the AGbind of the pMHC/TCR complexes with the
mm-pbsa method revealed the value of 188.3 kcal mol1 in the
TCR–HLAtpep. The corresponding value of the TCR–HLAcpep was
found 229.3 188.3 kcal mol1. Although the accuracy of the
these values can be disputed, the trend is in perfect agreement
Fig. 5. Hydrogen bond interactions at the pMHC/TCR interface. Time series of total
number of hydrgen bonds found in: (A) between MHC chain a and TCR chain a, (B)
between MHC chain a and TCR chain b, (C) between peptide a and TCR chain a, (D)
between peptide and TCR chain b, (E) between pMHC and TCR, the green line also
indicates the difference found between the TCR–HLAcpep and TCR–HLAtpep trajec-
tories, (F) between the peptide (residues 2–9) and water molecules, the green line
also indicates the difference found between the TCR–HLAcpep and TCR–HLAtpep
trajectories.
Fig. 6. Buried surface area time evolution in TCR–HLAcpep and TCR–HLAtpep MD
trajectories, of pMHC/TCR interface.
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of DM1 TCR for the cis peptide bond conformation in the pMHC
complex.
4. Discussion
Cis–trans isomerization of the bound peptide in pMHC/TCR
complexes is a rare phenomenon, that is presented here for the
ﬁrst time. Based on TCR–HLA-B*4405EENLLDFVRF and HLA-
B*4405EENLLDFVRF X-ray structures, two 20 ns molecular dynamics
trajectories have been employed, in order to elucidate the struc-
tural and energetic features of this conformational transition. De-
spite the energetic cost of cis–trans isomerization, the T-cell
receptor can introduce such a conformational transition to a pep-
tide bound to HLA-B*4405 molecule.
Energetic analysis of the two complexes revealed some interest-
ing features about the preference of the DM1 TCR for a pMHC com-
plex with the Leu5-Asp6 peptide bond in cis conformation. The
DGbind has been found considerably lower in TCR–HLAcpep than
in TCR–HLAtpep complex respectively. A single dihedral angle
differentiation is a small variation in a complex of 825 residues,
however, it effects critically the energetics of binding between
the TCR and pMHC complex. The ﬁndings from MM-PBSA results
are consistent with three other critical facts: (a) the decrease in
the buried surface are at pMHC/TCR interface, (b) the decrease in
hydrogen bond interactions between pMHC/TCR interface and (c)
the signiﬁcant increase in the hydration of the peptide. All these
factors corroborate the hypothesis the TCR–HLAtpep complex is rel-
atively unstable and that the cis peptide bond in the Leu5-Asp6 re-
gion in the energetically favourable conformation of the peptide in
the pMHC/TCR complex. The presence of a relatively rigid confor-
mation of the peptide in TCR–HLAcpep complex is also consistent
with a more favourable interaction mode. The cis isomerization
state of the Leu5-Asp6 bond in pMHC/TCR complex was also
accompanied by a beta-turn formation in the Leu5-Val8 region.
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